ELISA/assay

GENLISA™ Human Anti-SARS-CoV-2 IgG Antibody To Spike Protein ELISA (Quantitative)

KBVH015-8

1 x 96 wells

350 USD

GENLISA™ Human Anti-SARS-CoV-2 IgG Antibody To Spike Protein ELISA (Quantitative)

GENLISA™ Human Anti-SARS-CoV-2 IgG Antibody to Spike RBD Protein ELISA (Quantitative) - CE MARKED

ELISA

1 x 96 wells

350 USD

ELISA for the quantitative estimation of IgG antibodies to SARS-CoV-2 (Covid-19) Spike RBD protein in human serum, plasma and cell culture samples. CE marked for diagnostic use.

Human

The GENLISA™ ELISA kits are used for assessing the specific biomarker in samples analytes which may be serum, plasma and cell culture supernatant as validated with the kit. The kit employs a sandwich ELISA technique which leads to a higher specificity and increased sensitivity compared to conventional ELISA kits which employ only one antibody.

This ELISA kit comes with a pre-coated plate, concentrated or lyophilized standards, wash solution, subtrate, stop solution and all the required diluents. For the exact contents of the kit, please refer to the datasheet / IFU.

2 - 8 Deg C / dry ice at -20 Deg C

Qualitative

10 AU/ml

The method employs sandwich ELISA technique. Human SARS-CoV-2 spike protein is pre-coated onto microwells. Samples and standards are pipetted into microwells and IgG Antibodies to human SARS-CoV2 (Covid-19) present in the sample are bound by the protein antigen.After incubation the wells are washed and followed by HRP-conjugated Detection IgG Antibody is pipetted and incubated to form a complex. After washing microwells in order to remove any non-specific binding, the substrate solution (TMB) is added to microwells and color develops proportionally to the amount of IgG AntiHuman SARS-CoV-2 (Covid-19) in the sample. Color development is then stopped by addition of stop solution. Absorbance is measured at 450 nm.

SARS-CoV-2 IgG Antibody to Spike protein

CE IVD

2-8 degrees C